733 related articles for article (PubMed ID: 32786253)
1. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
Wan X; Song L; Pan W; Zhong H; Li N; Tang B
ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
[TBL] [Abstract][Full Text] [Related]
3. MOF-based nanozyme grafted with cooperative Pt(IV) prodrug for synergistic anticancer therapy.
Wu PH; Cheng PF; Kaveevivitchai W; Chen TH
Colloids Surf B Biointerfaces; 2023 May; 225():113264. PubMed ID: 36921426
[TBL] [Abstract][Full Text] [Related]
4. A Cascade Nanoreactor of Metal-Protein-Polyphenol Capsule for Oxygen-Mediated Synergistic Tumor Starvation and Chemodynamic Therapy.
Yu Q; Zhou J; Song J; Zhou H; Kang B; Chen HY; Xu JJ
Small; 2023 Feb; 19(5):e2206592. PubMed ID: 36437115
[TBL] [Abstract][Full Text] [Related]
5. A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy.
Cheng H; Jiang XY; Zheng RR; Zuo SJ; Zhao LP; Fan GL; Xie BR; Yu XY; Li SY; Zhang XZ
Biomaterials; 2019 Mar; 195():75-85. PubMed ID: 30616030
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy.
Shao F; Wu Y; Tian Z; Liu S
Biomaterials; 2021 Jul; 274():120869. PubMed ID: 33984636
[TBL] [Abstract][Full Text] [Related]
7. A Purposefully Designed pH/GSH-Responsive MnFe-Based Metal-Organic Frameworks as Cascade Nanoreactor for Enhanced Chemo-Chemodynamic-Starvation Synergistic Therapy.
Chen WJ; Gupta D; Yang M; Yang F; Feng N; Song J; Wood MJA; Qiu L; Chen J
Small; 2023 Dec; 19(50):e2303403. PubMed ID: 37649230
[TBL] [Abstract][Full Text] [Related]
8. Cascade nanozymes based on the "butterfly effect" for enhanced starvation therapy through the regulation of autophagy.
Yao H; Gong X; Geng M; Duan S; Qiao P; Sun F; Zhu Z; Du B
Biomater Sci; 2022 Jul; 10(14):4008-4022. PubMed ID: 35726640
[TBL] [Abstract][Full Text] [Related]
9. Urchin-Shaped Metal Organic/Hydrogen-Bonded Framework Nanocomposite as a Multifunctional Nanoreactor for Catalysis-Enhanced Synergetic Therapy.
Hu C; Wang J; Liu S; Cai L; Zhou Y; Liu X; Wang M; Liu Z; Pang M
ACS Appl Mater Interfaces; 2021 Feb; 13(4):4825-4834. PubMed ID: 33496168
[TBL] [Abstract][Full Text] [Related]
10. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
[No Abstract] [Full Text] [Related]
11. A dual-catalytic nanoreactor for synergistic chemodynamic-starvation therapy toward tumor metastasis suppression.
Zhang H; Lu F; Pan W; Ge Y; Cui B; Gong S; Li N; Tang B
Biomater Sci; 2021 May; 9(10):3814-3820. PubMed ID: 33881052
[TBL] [Abstract][Full Text] [Related]
12. A pH-activated autocatalytic nanoreactor for self-boosting Fenton-like chemodynamic therapy.
Wu H; Chen F; Gu D; You C; Sun B
Nanoscale; 2020 Sep; 12(33):17319-17331. PubMed ID: 32789333
[TBL] [Abstract][Full Text] [Related]
13. Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy.
Liu Y; Qi P; Chen G; Lang Z; Wang J; Wang X
Biomater Adv; 2024 Feb; 157():213758. PubMed ID: 38199000
[TBL] [Abstract][Full Text] [Related]
14. Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy.
Ming J; Zhu T; Yang W; Shi Y; Huang D; Li J; Xiang S; Wang J; Chen X; Zheng N
ACS Appl Mater Interfaces; 2020 Nov; 12(46):51249-51262. PubMed ID: 33161703
[TBL] [Abstract][Full Text] [Related]
15. Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors.
Yao Z; Zhang B; Liang T; Ding J; Min Q; Zhu JJ
ACS Appl Mater Interfaces; 2019 May; 11(21):18995-19005. PubMed ID: 31058483
[TBL] [Abstract][Full Text] [Related]
16. An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy.
Liu X; Gao P; Shi M; Chen Y; Pan W; Li N; Tang B
Biomater Sci; 2022 Jun; 10(12):3088-3091. PubMed ID: 35616209
[TBL] [Abstract][Full Text] [Related]
17. Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor.
Zhang K; Ma Z; Li S; Wu Y; Zhang J; Zhang W; Zhao Y; Han H
Biomaterials; 2022 May; 284():121502. PubMed ID: 35390708
[TBL] [Abstract][Full Text] [Related]
18. A flowerlike FePt/MnO
Kou Y; Dai Z; Cui P; Hu Z; Tian L; Zhang F; Duan H; Xia Q; Liu Q; Zheng X
J Mater Chem B; 2021 Oct; 9(40):8480-8490. PubMed ID: 34553729
[TBL] [Abstract][Full Text] [Related]
19. Phosphate-Degradable Nanoparticles Based on Metal-Organic Frameworks for Chemo-Starvation-Chemodynamic Synergistic Antitumor Therapy.
Peng H; Qin YT; Feng YS; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37713-37723. PubMed ID: 34340302
[TBL] [Abstract][Full Text] [Related]
20. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
